A recent market report from the Venture Planning Group covers the infectious disease testing market which is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century.

Among the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world's major health threat and a major factor contributing to the rise in incidence of opportunistic infections bioterrorism advances in molecular diagnostic technologies and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
This comprehensive worldwide survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides a market segmentation analysis of over 70 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.

Contains 1,900 pages and 820 tables.

Click the More Information button below to receive more details.